Revenue
$725.2m
+65.3% ↑ vs $438.7m
Large-event claims of NZ$38.2m drove underwriting into loss and operating cash inflow fell to NZ$10.0m, straining solvency and capital return.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY23 vs FY22
Revenue
$725.2m
+65.3% ↑ vs $438.7m
Net profit after tax
−$1.2m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$10m
-83.3% ↓ vs $59.8m
Declared dividend per share
—
— vs 4.0c
Operating profit
−$11.7m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
$7.4m
-70.6% ↓ vs $25.2m
Cash and cash equivalents
$64m
-24.3% ↓ vs $84.5m
Total assets
$946.2m
+17.7% ↑ vs $804.2m
What changed
Net earned premium grew to NZ$416.3m from NZ$361.1m, but the reported result became a NZ$1.2m loss versus an NZ$18.9m profit, and no FY23 dividend was declared (FY22 included a 4.0 cent final).
Operating cash inflow fell to NZ$10.0m from NZ$59.8m, an 83.3% decline. Pre-lease free cash flow of NZ$7.5m is the weakest in Annolyse's historical baseline for Tower (4-period mean NZ$109.4m, range NZ$56.6m–NZ$142.8m). The disclosed solvency position was materially reduced (23% reported, versus 205% disclosed in FY22), and management explicitly tied the no-dividend decision to large-event impacts on profit and solvency.
What matters
A combined ratio of 101.0% means claims and expenses exceeded premium earned before any investment contribution. The large-events ratio rose to 13.4% from 5.3%, but the business-as-usual claims ratio also worsened to 55.5% from 48.9%. This matters because it tests whether targeted rate increases are enough to restore underwriting profitability without help from a benign weather year.
Catastrophes consumed capital and dictated the payout decision. With the solvency position weakened and large-event claims doubling, the board declared no FY23 dividend. Capital adequacy, not earnings ambition, is currently setting payout policy, which is the relevant frame for assessing when distributions can resume.
Cash generation collapsed against the historical baseline. Pre-lease free cash flow of NZ$7.5m versus a 4-period historical mean of NZ$109.4m is classified as unprecedentedly low in the supplied baseline. For a general insurer, this matters because cash is what funds reinsurance, claims settlements, and solvency headroom, so a thin year amplifies pressure heading into the FY24 reinsurance program.
Expectations
The half-year context shows HY23 reported a NZ$5.1m loss, so the implied second half delivered a small positive NPAT of NZ$3.9m but operating cash flow of -NZ$8.2m; the second half stabilised earnings without repairing cash.
With the FY24 catastrophe budget reset, continued rate increases, and net investment income running NZ$13.1m higher on yields, the recovery thesis is plausible but conditional on a more normal large-events year. The release does not quantify what a sub-100% combined ratio assumes for claims inflation or perils experience, so the path back to underwriting profit and dividend resumption is asserted, not parameterised.
Quality of result
Net investment income lifted by NZ$13.1m on higher yields and offset some of the underwriting pressure; that benefit is rate-driven rather than underwriting-quality-driven, and would moderate if rates fall. Total revenue at NZ$725.2m versus NZ$438.7m is not a like-for-like underlying movement, given basis-discontinuity caveats in the supplied data and the discontinued-operation overlay tied to disclosed Papua New Guinea and Suva exits; net earned premium growth (NZ$416.3m vs NZ$361.1m) is the cleaner premium read.
The effective tax rate of 68.4% sits well outside Tower's historical range (4-period mean 30.5%, range 28.9%–32.1%, classified as unprecedentedly high in the supplied baseline). That reflects the arithmetic of a small pre-tax profit alongside a NZ$3.6m discontinued-operation loss, so PBT and NPAT growth comparisons to FY22 are not directly meaningful and analytical-calculation values for those growth lines carry basis-discontinuity caveats. The cleanest reads of FY23 quality are the combined ratio, the BAU claims ratio, and operating cash flow, all of which point to a materially weaker year than headline revenue suggests.
Unresolved
This briefing cannot assess FY24 catastrophe outcomes, reinsurance pricing changes, or whether the announced rate actions will fully offset underlying claims inflation.
Chat
Ask follow-up questions about Tower's FY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Annual Report (including Financial Statements)
FY23 / financial reportResults Announcement
FY23 / results announcementResults Announcement
FY23 / results releaseResults Presentation
FY23 / results presentationAnnual Report
FY22 / financial reportTower HY23 Financial Statements (including auditor's report)
HY23 / financial reportTower HY23 Media Release
HY23 / media releaseTower HY23 Results Announcement
HY23 / results announcementTower HY23 Results Announcement Presentation
HY23 / results presentationTower updates FY23 guidance and large events costs
FY23 / commentaryAnnual Meeting Address
HY23 / commentaryTower Updates Guidance, Provides Update on Large Events
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Get the next Tower briefing and related NZX reporting-season updates by email.